Over the past decade Progressive has achieved an average combined ratio of 92.2%, reflecting its ability to scale gross written premiums from $19.6 billion in 2014 to $65.5 billion in 2024 while maintaining expense ratios below 20%. This disciplined approach has delivered durable underwriting profits across multiple underwriting cycles. In its most recent quarterly report, the company recorded a net margin of 12.6% and a return on equity of 33.9%, underscoring the effectiveness of its cost controls and risk selection in personal auto and specialty casualty lines.

Twenty-two brokerages covering Progressive have delivered an average recommendation of Hold, with analysts split between two Sell ratings, twelve Hold ratings, seven Buys and one Strong Buy. The average 12-month target price stands at approximately $260.74. Notable recent actions include Morgan Stanley’s reaffirmation of an Underweight stance, Citigroup’s Buy rating alongside a modest target revision downward, Zacks Research’s downgrade from Strong Buy to Hold, Barclays’ upgrade from Equal Weight to Overweight with a raised target, and Goldman Sachs’ issuance of a $227.00 target.

Insider activity over the past three months shows CFO John P. Sauerland selling 5,000 shares and another senior executive disposing of 1,344 shares, reducing their positions by 2.2% and 4.9% respectively. Combined insider sales totaled 9,034 shares valued at roughly $2.05 million, leaving insiders with 0.34% ownership. Concurrently, institutional investors hold 85.34% of the equity. Recent adjustments include Brighton Jones LLC increasing its stake by 15.6%, Revolve Wealth Partners initiating a new position, and HBW Advisory Services lifting its holdings by 37.5%, reflecting both tactical and strategic reallocations among major funds.